Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00480597
Status:
COMPLETED
Last Update Posted:
2010-10-28
First Post:
2007-05-30
Brief Title:
GemcitabineVinorelbine Versus GemcitabineCisplatin Versus GemcitabineCapecitabine in Metastatic Breast Cancer
Sponsor:
Ludwig-Maximilians - University of Munich
Organization:
Ludwig-Maximilians - University of Munich
Organization Data
Organization:
Ludwig-Maximilians - University of Munich
Class:
OTHER
Study ID:
Gemcitabin 02 MC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None